Date: 2014-09-08 13:35:42

SEC filings

Mergers and acquisitions

Allergan

Auditing

United States corporate law

United States securities law

Biovail

Valeant Pharmaceuticals

J. Michael Pearson

Business

Accountancy

Finance

Additional rebuttal items Source Allergan September 3rd Answer to CA federal suit

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 474,40 KB